Evident Vascular Receives FDA Clearance for High-Fidelity AI Powered IVUS Imaging Platform

Share this story

SAN JOSE, Calif.–(BUSINESS WIRE)–Evident Vascular, Inc., today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Evident Vascular® Guidance System and Evident® peripheral imaging catheters. The Evident Vascular Guidance System is intended for ultrasound examination of intravascular pathology during peripheral vascular interventions. The Evident platform is designed to transform the IVUS imaging experience by bringing together high-fidelity imaging, purpose-built AI, an

See the full post here as oringinally posted on this site.

Leave a Comment

Your email address will not be published. Required fields are marked *

*